The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2

Published:2015-08-14 Issue:16 Volume:14 Page:2688-2700
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Jamal Azfar¹,Swarnalatha Manickavinayaham¹,Sultana Sarwat²,Joshi Prashant³,Panda Subrat K.³,Kumar Vijay¹

Affiliation:

1. Virology Group; International Center for Genetic Engineering and Biotechnology; New Delhi, India

2. Department of Medical Elementology and Toxicology; Faculty of Science, Jamia Hamdard; New Delhi, India

3. Department of Pathology; All India Institute of Medical Sciences; New Delhi, India

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2015.1056946

Reference48 articles.

1. Targeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology

2. Ubiquitin ligases: cell-cycle control and cancer

3. Ubiquitin-mediated control of oncogene and tumor suppressor gene products

4. Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer

5. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the ubiquitin code in pancreatic cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01

2. Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy;Breast Cancer: Targets and Therapy;2022-12

3. Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy;Seminars in Cancer Biology;2022-12

4. The Hepatitis B Virus Interactome: A Comprehensive Overview;Frontiers in Microbiology;2021-09-16

5. Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy;Frontiers in Oncology;2021-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3